Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut.
Department of Orthopaedics and Rehabilitation, University of New Mexico, Albuquerque, New Mexico.
J Bone Joint Surg Am. 2023 Jul 5;105(13):1012-1019. doi: 10.2106/JBJS.23.00079. Epub 2023 May 15.
Multiligament knee injury (MLKI) with associated extensor mechanism (EM) involvement is a rare injury, with limited evidence to guide optimal treatment. The purpose of this study was to identify areas of consensus among a group of international experts regarding the treatment of patients with MLKI and concomitant EM injury.
Utilizing a classic Delphi technique, an international group of 46 surgeons from 6 continents with expertise in MLKI undertook 3 rounds of online surveys. Participants were presented with clinical scenarios involving EM disruption in association with MLKI, classified using the Schenck Knee-Dislocation (KD) Classification. Positive consensus was defined as ≥70% agreement with responses of either "strongly agree" or "agree," and negative consensus was defined as ≥70% agreement with "strongly disagree" or "disagree."
There was a 100% response rate for rounds 1 and 2 and a 96% response rate for round 3. There was strong positive consensus (87%) that an EM injury in combination with MLKI significantly alters the treatment algorithm. For an EM injury in conjunction with a KD2, KD3M, or KD3L injury, there was positive consensus to repair the EM injury only and negative consensus regarding performing concurrent ligamentous reconstruction at the time of initial surgery.
In the setting of bicruciate MLKI, there was overall agreement on the significant impact of EM injury on the treatment algorithm. We therefore recommend that the Schenck KD Classification be updated with the addition of the modifier suffix "-EM" to highlight this impact. Treatment of the EM injury was judged to have the highest priority, and there was consensus to treat the EM injury only. However, given the lack of clinical outcome data, treatment decisions need to be made on a case-by-case basis with consideration of the numerous clinical factors that are encountered.
Little clinical evidence exists to guide the surgeon on the management of EM injury in the setting of a multiligament injured or dislocated knee. This survey highlights the impact that EM injury has on the treatment algorithm and provides some guidance for management until a further large case series or prospective studies are undertaken.
多韧带膝关节损伤(MLKI)伴伸肌机制(EM)受累较为少见,目前仅有少量证据可用于指导最佳治疗方法。本研究旨在确定一组国际专家在治疗 MLKI 合并 EM 损伤患者方面的共识领域。
利用经典的 Delphi 技术,来自 6 大洲、在 MLKI 方面具有专业知识的 46 名外科医生组成了一个国际小组,进行了 3 轮在线调查。参与者需要对 EM 破坏与 MLKI 相关的临床情况进行分类,采用 Schenck 膝关节脱位(KD)分类。阳性共识定义为“强烈同意”或“同意”的回答比例≥70%,阴性共识定义为“强烈不同意”或“不同意”的回答比例≥70%。
第 1 轮和第 2 轮的回复率为 100%,第 3 轮的回复率为 96%。对于 MLKI 合并 EM 损伤会显著改变治疗方案,有 87%的专家表示强烈赞同。对于 EM 损伤与 KD2、KD3M 或 KD3L 损伤同时存在的情况,专家们仅对修复 EM 损伤表示赞同,而对初次手术时同时进行韧带重建持否定意见。
在双交叉韧带 MLKI 损伤的情况下,对于 EM 损伤对治疗方案的显著影响,专家们基本达成一致意见。因此,我们建议在 Schenck KD 分类中添加修饰词后缀“-EM”,以突出这一影响。EM 损伤的治疗被认为是首要任务,专家们一致认为仅治疗 EM 损伤即可。然而,由于缺乏临床结果数据,在处理大量临床因素的基础上,需要根据具体情况进行决策。
目前几乎没有临床证据可用于指导外科医生处理多韧带损伤或脱位膝关节中的 EM 损伤。本调查强调了 EM 损伤对治疗方案的影响,并为管理提供了一些指导,直到进一步开展大型病例系列或前瞻性研究。